These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35330909)

  • 1. Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators.
    Sánchez-Rodríguez MB; Téllez É; Casulleras M; Borràs FE; Arroyo V; Clària J; Sarrias MR
    Front Immunol; 2022; 13():842996. PubMed ID: 35330909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
    López-Vicario C; Checa A; Urdangarin A; Aguilar F; Alcaraz-Quiles J; Caraceni P; Amorós A; Pavesi M; Gómez-Cabrero D; Trebicka J; Oettl K; Moreau R; Planell N; Arroyo V; Wheelock CE; Clària J
    J Hepatol; 2020 Oct; 73(4):817-828. PubMed ID: 32294533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content.
    Bárcena C; Aran G; Perea L; Sanjurjo L; Téllez É; Oncins A; Masnou H; Serra I; García-Gallo M; Kremer L; Sala M; Armengol C; Sancho-Bru P; Sarrias MR
    EBioMedicine; 2019 May; 43():513-524. PubMed ID: 31076347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
    Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
    Front Immunol; 2019; 10():476. PubMed ID: 30941129
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
    Moreau R; Clària J; Aguilar F; Fenaille F; Lozano JJ; Junot C; Colsch B; Caraceni P; Trebicka J; Pavesi M; Alessandria C; Nevens F; Saliba F; Welzel TM; Albillos A; Gustot T; Fernández J; Moreno C; Baldassarre M; Zaccherini G; Piano S; Montagnese S; Vargas V; Genescà J; Solà E; Bernal W; Butin N; Hautbergue T; Cholet S; Castelli F; Jansen C; Steib C; Campion D; Mookerjee R; Rodríguez-Gandía M; Soriano G; Durand F; Benten D; Bañares R; Stauber RE; Gronbaek H; Coenraad MJ; Ginès P; Gerbes A; Jalan R; Bernardi M; Arroyo V; Angeli P; ; ;
    J Hepatol; 2020 Apr; 72(4):688-701. PubMed ID: 31778751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis.
    Clària J; Curto A; Moreau R; Colsch B; López-Vicario C; Lozano JJ; Aguilar F; Castelli FA; Fenaille F; Junot C; Zhang I; Vinaixa M; Yanes O; Caraceni P; Trebicka J; Fernández J; Angeli P; Jalan R; Arroyo V
    J Hepatol; 2021 Nov; 75(5):1116-1127. PubMed ID: 34245803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of non-thyroidal illness syndrome in acute decompensation of liver cirrhosis and acute-on-chronic liver failure.
    Langer MM; Bauschen A; Guckenbiehl S; Klauss S; Lutz T; Denk G; Zwanziger D; Moeller LC; Lange CM
    Front Endocrinol (Lausanne); 2023; 14():1104388. PubMed ID: 36755907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure.
    Zhang IW; Curto A; López-Vicario C; Casulleras M; Duran-Güell M; Flores-Costa R; Colsch B; Aguilar F; Aransay AM; Lozano JJ; Hernández-Tejero M; Toapanta D; Fernández J; Arroyo V; Clària J
    J Hepatol; 2022 Jan; 76(1):93-106. PubMed ID: 34450236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
    J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
    Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V;
    Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
    Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
    Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation.
    Schwarzkopf KM; Queck A; Thomas D; Angioni C; Cai C; Freygang Y; Rüschenbaum S; Geisslinger G; Zeuzem S; Welsch C; Lange CM
    PLoS One; 2019; 14(1):e0211537. PubMed ID: 30703151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure.
    Casulleras M; Zhang IW; López-Vicario C; Clària J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
    Kerbert AJC; Gupta S; Alabsawy E; Dobler I; Lønsmann I; Hall A; Nielsen SH; Nielsen MJ; Gronbaek H; Amoros À; Yeung D; Macnaughtan J; Mookerjee RP; Macdonald S; Andreola F; Moreau R; Arroyo V; Angeli P; Leeming DJ; Treem W; Karsdal MA; Jalan R
    JHEP Rep; 2021 Dec; 3(6):100355. PubMed ID: 34805815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
    Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
    [No Abstract]   [Full Text] [Related]  

  • 19. Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
    Hoshi H; Chu PS; Yoshida A; Taniki N; Morikawa R; Yamataka K; Noguchi F; Kasuga R; Tabuchi T; Ebinuma H; Saito H; Kanai T; Nakamoto N
    PLoS One; 2021; 16(4):e0250062. PubMed ID: 33848309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF.
    Zaccherini G; Aguilar F; Caraceni P; Clària J; Lozano JJ; Fenaille F; Castelli F; Junot C; Curto A; Formentin C; Weiss E; Bernardi M; Jalan R; Angeli P; Moreau R; Arroyo V
    J Hepatol; 2021 May; 74(5):1117-1131. PubMed ID: 33276029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.